A comprehensive view of Clinical Trials. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.
Recent Articles
sample of recent headlines, press releases and get more..
FDA places partial hold on late-stage study of Sanofi’s tolebrutinib to treat patients with multiple sclerosis, myasthenia gravis; FDA cites limited number of cases of drug-induced liver injury as cause for hold
Published:
July 05, 2022
by SeeNews Pharmaceuticals
|
McKesson and HCA Healthcare form JV combining McKesson’s US Oncology Research, HCA’s Sarah Cannon Research Institute to expand research, drug development, availability to clinical trials; McKesson also acquires Genospace personal medicine platform
Published:
July 01, 2022
by Business Wire
|
GlycosBio to start recruiting for clinical trial to assess effect modified plant oil has on OTC colloidal oatmeal formulation to treat eczema; US study to be completed by March 2024
Published:
June 30, 2022
by Clinical Trials Daily
|
Children's Hospital Los Angeles collaborates with United Therapeutics on Phase 4 clinical trial to study rapid infusion of Dinutuximab to treat children with high-risk neuroblastoma, a cancer of the nerve cells; study not yet open for recruiting
Published:
June 29, 2022
by Contify Life Science News
|
Bristol Myers Squibb reports mRNA vaccines more effective at developing COVID-19 antibodies in multiple sclerosis patients treated with oral Zeposia ozanimod than non-mRNA vaccines; observation may help in assisting physicians seeking to optimize care
Published:
June 29, 2022
by SeeNews Pharmaceuticals
|
Ask us about our Government & Public Policy market view
Trending Chart
Interactive chart with headline count